Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 26, 2007

Aruna to Make Human Neural Cells from University of Georgia Available to Researchers

  • Aruna Biomedical will commercialize human neural progenitor cell technology developed at the University of Georgia Research Foundation.

    Under the terms of the technology licensing agreement, Aruna acquired the exclusive worldwide right to develop and commercialize neural cells derived from human embryonic stem cells. Aruna will offer the academic and industry research communities access to much sought after but never before available human neural cells, derived from human embryonic stem cells that relate to normal and diseased human conditions .

    Aruna anticipates launch of its first product, human neural progenitor (NP) cells, in early 2007 and add-on products will closely follow. The human NP cells will be sold and marketed through a third-party distribution partner and packaged as a kit with growth media and substrates.



Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »